Our models predict that the AD risk allele led to lower regulatory activity, and this direction of effect is consistent with the Novikova et al. [18] study that showed that the risk allele disrupts a CTCF transcription factor binding site to decrease regulatory activity. The gene discussed is CTCF; the disease is Alzheimer disease.